Le Lézard
Classified in: Science and technology
Subjects: Photo/Multimedia, Product/Service, Sales

Global shipments of Rokid Air exceed 30,000 Worldwide


According to supply chain data, Rokid's consumer product, the Rokid Air, became the first consumer augmented reality (AR) gadget reaching global sales numbers in excess of 30,000 units on August 18, 2022.

In September 2021, Rokid launched its consumer AR smart glasses, the Rokid Air. The world's first AR glasses, that weigh only 83 grams. The Rokid Air's compact, lightweight, and aesthetically pleasing design, as well as its foldable body, makes it easy to carry it around. The 43-degree FoV and dual HD directional speaker provide consumers the best-in-class movie and gaming experience.

Rokid, a product platform company founded in 2014, focuses on human-computer interaction technology. Currently, Rokid is working on the research and development of hardware and software products such as AR glasses and the YodaOS-XR ecological project. Through the research of speech recognition, natural language processing, optical display, semiconductor platform, and hardware design, Rokid has developed a range of augmented reality (AR) glasses for customers such as the Rokid Air consumer AR glasses that were released in 2021. To date, the company's products have been sold and used in over 70 countries and regions worldwide.


These press releases may also interest you

at 18:05
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

at 13:27
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

at 10:15
"Maximizing customer retention and expansion is more important than ever for B2B SaaS companies," said Steven Forth, CEO of Ibbaka. "Our...

at 08:35
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...

at 07:05
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...

at 06:47
After tens of thousands of NYC children were turned away from "Summer Rising," New York City's popular, free summer enrichment program, Brains & Motion launched a campaign offering camps at NYU for a small fraction of the up-to-$1400 per week price...



News published on and distributed by: